SM
JAZZ icon

Stephen Mandel’s Jazz Pharmaceuticals JAZZ Stock Holding History

Stephen Mandel’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-260,985
Closed -$45.1M – 62
2015
Q1 		$45.1M Sell
260,985
-1,622,669
-86% -$278M 0.17% 53
2014
Q4 		$308M Buy
1,883,654
+95,047
+5% +$15.8M 1.29% 25
2014
Q3 		$287M Sell
1,788,607
-298,520
-14% -$45.9M 1.12% 34
2014
Q2 		$307M Sell
2,087,127
-257,359
-11% -$35.7M 1.24% 28
2014
Q1 		$325M Buy
+2,344,486
New +$353M 1.41% 27

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.62B AUM 39.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stephen Mandel's JAZZ Position: Q2 2015 in Review

Stephen Mandel sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2015, closing a stake of 260,985 shares — an estimated $45.1M sold.

Stephen Mandel first reported a position in JAZZ in Q1 2014 and held it in 5 quarters. The position peaked at $325M in Q1 2014. 374 funds tracked by Wall St. Rank hold JAZZ as of Q2 2015.

  • Stephen Mandel reported no remaining Jazz Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Stephen Mandel sold 260,985 Jazz Pharmaceuticals shares in Q2 2015, an estimated $45.1M.
  • Stephen Mandel first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 5 quarters.
  • Stephen Mandel's Jazz Pharmaceuticals position peaked at $325M in Q1 2014.
  • 374 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2015.

Based on Lone Pine Capital's 13F filing for Q2 2015, filed 14 Aug 2015.